Herbert Loong: The status of early Lung Cancer detection and screening in the Asia Pacific region
Herbert Loong, Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong, shared a post on LinkedIn:
“Thanks Jean-Yves Blay and the ESMO – European Society for Medical Oncology, public policy team for providing a forum for us to discuss the status of early lung cancer detection and screening in the Asia Pacific region.
This is an important and timely topic as understand the differing pathophysiology and molecular epidemiology of Asian lung cancer possibly requiring a different approach.”
Herbert H. F. Loong is the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO). Additionally, he has been promoted to Steering Committee Member at the Lung Cancer Policy Network. Dr. Loong is also the Chairperson of the Asia Pacific Coalition against Lung Cancer, a Board Member of the Connective Tissue Oncology Society, and a Committee Member of the International Association for the Study of Lung Cancer. He is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK).
More posts featuring Herbert Loong.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023